Serum leucine‐rich alpha‐2 glycoprotein in monitoring disease activity and intestinal mucosal healing for biotherapy‐naïve cases with ulcerative colitis

Abstract Background and Aim Serum leucine‐rich alpha‐2 glycoprotein level has been reported to be a useful biomarker in assessing mucosal healing in patients undergoing biotherapy, where mucosal lesions caused by ulcerative colitis are difficult to assess endoscopically. However, no such reports hav...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Masashi Kono, Yoriaki Komeda, George Tribonias, Saki Yoshida, Kenji Nomura, Kohei Handa, Tomoyuki Nagai, Satoru Hagiwara, Shunsuke Omoto, Mamoru Takenaka, Naoshi Nishida, Naoko Tsuji, Hiroshi Kashida, Masatoshi Kudo
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Wiley 2023-08-01
Serie:	JGH Open
Ämnen:	biotherapy‐naïve leucine‐rich alpha‐2 glycoprotein ulcerative colitis
Länkar:	https://doi.org/10.1002/jgh3.12953
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!